BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8224265)

  • 1. Clinical and endocrine effects of flutamide in hyperandrogenic women.
    Fruzzetti F; De Lorenzo D; Ricci C; Fioretti P
    Fertil Steril; 1993 Nov; 60(5):806-13. PubMed ID: 8224265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
    Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho J; Varela C
    Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of 250 mg/day flutamide in the treatment of patients with hirsutism.
    Müderris II; Bayram F; Sahin Y; Keleştimur F; Tutuş A; Ayata D
    Fertil Steril; 1996 Aug; 66(2):220-2. PubMed ID: 8690105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism.
    Couzinet B; Pholsena M; Young J; Schaison G
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):157-62. PubMed ID: 8370128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a long-acting gonadotropin-releasing hormone analog on the pituitary-ovarian-adrenal axis in women with severe hirsutism.
    Castelo-Branco C; Martínez de Osaba MJ; Martínez S; Fortuny A
    Metabolism; 1996 Jan; 45(1):24-7. PubMed ID: 8544772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
    De Leo V; Fulghesu AM; la Marca A; Morgante G; Pasqui L; Talluri B; Torricelli M; Caruso A
    Gynecol Endocrinol; 2000 Dec; 14(6):411-6. PubMed ID: 11228061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of lower dose flutamide 125 mg/day in the treatment of hirsutism.
    Müderris II; Bayram F
    J Endocrinol Invest; 1999 Mar; 22(3):165-8. PubMed ID: 10219882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal function in hirsutism I. Diurnal change and response of plasma androstenedione, testosterone, 17-hydroxyprogesterone, cortisol, LH and FSH to dexamethasone and 1/2 unit of ACTH.
    Givens JR; Andersen RN; Ragland JB; Wiser WL; Umstot ES
    J Clin Endocrinol Metab; 1975 Jun; 40(6):988-1000. PubMed ID: 166091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of androgens in menstrual disorders of nonhirsute and hirsute women, and the effect of glucocorticoid therapy on androgen levels in hirsute hyperandrogenic women.
    Ho Yuen B; Mincey EK
    Am J Obstet Gynecol; 1983 Jan; 145(2):152-7. PubMed ID: 6401396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects.
    Fruzzetti F; Bersi C; Parrini D; Ricci C; Genazzani AR
    Fertil Steril; 1999 Mar; 71(3):445-51. PubMed ID: 10065780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hirsutism in women with flutamide.
    Marcondes JA; Minnani SL; Luthold WW; Wajchenberg BL; Samojlik E; Kirschner MA
    Fertil Steril; 1992 Mar; 57(3):543-7. PubMed ID: 1531466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
    Bertoli A; Fusco A; Magnani A; Marini MA; Di Daniele N; Gatti S; Lauro R
    Exp Clin Endocrinol Diabetes; 1995; 103(1):15-20. PubMed ID: 7621099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The grade of hirsutism correlated to serum androgen levels and hormonal indices.
    Ruutiainen K; Erkkola R; Kaihola HL; Santti R; Irjala K
    Acta Obstet Gynecol Scand; 1985; 64(8):629-33. PubMed ID: 2938400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of flutamide in the management of hirsutism.
    Marugo M; Bernasconi D; Meozzi M; Del Monte P; Zino V; Primarolo P; Badaracco B
    J Endocrinol Invest; 1994 Mar; 17(3):195-9. PubMed ID: 8051342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian and adrenal contribuion to peripheral steroids during the menstrual cycle in two hirsute women.
    Abraham GE
    Obstet Gynecol; 1975 Jul; 46(1):29-36. PubMed ID: 1153134
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and endocrine effects of finasteride, a 5 alpha-reductase inhibitor, in women with idiopathic hirsutism.
    Ciotta L; Cianci A; Calogero AE; Palumbo MA; Marletta E; Sciuto A; Palumbo G
    Fertil Steril; 1995 Aug; 64(2):299-306. PubMed ID: 7615107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menstrual history as a determinant of current bone density in young hirsute women.
    Castelo-Branco C; Pons F; Martinez de Osaba MJ; Garrido J; Fortuny A
    Metabolism; 1996 Apr; 45(4):515-8. PubMed ID: 8609841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine parameters in acne vulgaris.
    Schmidt JB; Lindmaier A; Spona J
    Endocrinol Exp; 1990 Dec; 24(4):457-64. PubMed ID: 2151388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of an oral contraceptive containing ethinylestradiol and desogestrel on hair growth and hormonal parameters of hirsute women.
    Ruutiainen K
    Int J Gynaecol Obstet; 1986 Oct; 24(5):361-8. PubMed ID: 2880770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.